SusanFayeDentMD

Oncology • Rochester, NY

Physician

Join to view full profile

Dr. Dent is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
Connect with colleagues in the same hospital or clinic.
Read the latest clinical news, personalized to your specialty.

See Dr. Dent's full profile

Already have an account?

Office
601 Elmwood Ave
# 704
Rochester, NY 14642
Phone+1 919-613-4077

Fax+1 919-613-4077

Education & Training

Michael G. DeGroote School of MedicineClass of 1990

Certifications & Licensure

NY State Medical License 2024 - 2026
NC State Medical License 2018 - 2024

Clinical Trials

Glucagon Receptor Inhibition to Enable Breast Cancer Patients to Benefit From PI3K Inhibitor Therapy (REMD-477) Start of enrollment: 2020 Nov 13
Terminated
Phase 1
STOP-HER2: Stopping Trastuzumab in HER2+ MBC Start of enrollment: 2023 Apr 19
Recruiting
Phase 2
Roles: Contact, Principal Investigator

Publications & Presentations

PubMed

424 citations
Cardiotoxicity of anticancer treatments: Epidemiology, detection, and management
Giuseppe Curigliano, Daniela Cardinale, Susan Dent, Carmen Criscitiello, Olexiy Aseyev
CA. 2016-07-01
67 citations
Defining cardiovascular toxicities of cancer therapies: an International Cardio-Oncology Society (IC-OS) consensus statement.
Joerg Herrmann, Daniel Lenihan, Saro Armenian, Ana Barac, Anne Blaes
European Heart Journal. 2022-01-31
510 citations
Management of cardiac disease in cancer patients throughout oncological treatment: ESMO consensus recommendations
Giuseppe Curigliano, Daniel J. Lenihan, Michael G. Fradley, Sarju Ganatra, Ana Barac
Annals of Oncology. 2020-02-01

Authored Content

Cardio-Oncology Is a Growing Subspecialty, but Where Are the OncologistsFebruary 2024
Advances in the Treatment of Hormone Receptor Positive and HER-2 Positive Breast CancerDecember 2022

Press Mentions

Atrium Health Receives Grant to Help Researchers Uncover Signs of Heart Damage in Breast Cancer SurvivorsJuly 7th, 2022
Professor Receives Grant to Develop Breast Cancer Therapy That Combats Drug ResistanceSeptember 20th, 2021
PREFECT Trial Outcomes Demonstrate MyoStrain® Ability to Detect & Predict Early Cardiotoxicity in Cancer Patients Undergoing ChemotherapyJune 23rd, 2021
Join now to see all